Loading…

Aggressive surgical resection for hilar cholangiocarcinoma: is it justified? Audit of a single center's experience

Abstract Background The current study presents our experience with resectional surgery for patients with hilar cholangiocarcinoma (HC). Methods Medical records of 73 HC patients who were referred to our department between 1988 and 2006 were reviewed. Resectability rate, surgical mortality, and facto...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of surgery 2008-08, Vol.196 (2), p.160-169
Main Authors: Konstadoulakis, Manousos M., M.D., Ph.D, Roayaie, Sasan, M.D, Gomatos, Ilias P., M.D, Labow, Daniel, M.D, Fiel, Maria-Isabell, M.D, Miller, Charles M., M.D, Schwartz, Myron E., M.D
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Background The current study presents our experience with resectional surgery for patients with hilar cholangiocarcinoma (HC). Methods Medical records of 73 HC patients who were referred to our department between 1988 and 2006 were reviewed. Resectability rate, surgical mortality, and factors contributing to survival were investigated. Results Resectional surgery was performed in 59 patients (80.8%), 51 of whom (86.4%) underwent major hepatic resection. Negative margins were obtained in 35 of 51 patients (68.6%) and were associated with right-sided hepatectomy (80% vs 20%, P = .049). In-hospital mortality and morbidity were 6.8% and 25.4%, respectively. One-, 3- and 5-year survival rates after liver resection were 86%, 48.9%, and 34.9%, respectively. Histologic differentiation, left-sided hepatectomy, and inferior vena cava resection independently predicted survival. Patients undergoing R1 hepatectomy had significantly improved 5-year survival rates compared with patients who were unresectable ( P
ISSN:0002-9610
1879-1883
DOI:10.1016/j.amjsurg.2007.07.033